Doximity Inc (DOCS)vsTempus AI, Inc. Class A Common Stock (TEM)
DOCS
Doximity Inc
$20.07
-0.53%
HEALTHCARE · Cap: $3.66B
TEM
Tempus AI, Inc. Class A Common Stock
$47.85
-11.16%
HEALTHCARE · Cap: $9.13B
Smart Verdict
WallStSmart Research — data-driven comparison
Tempus AI, Inc. Class A Common Stock generates 112% more annual revenue ($1.36B vs $644.86M). DOCS leads profitability with a 30.4% profit margin vs -22.2%. DOCS earns a higher WallStSmart Score of 62/100 (C+).
DOCS
Buy62
out of 100
Grade: C+
TEM
Avoid31
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+49.5%
Fair Value
$51.38
Current Price
$20.07
$31.31 discount
Intrinsic value data unavailable for TEM.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Keeps 30 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Every $100 of equity generates 21 in profit
Growing faster than its price suggests
Strong operational efficiency at 21.6%
Revenue surging 36.1% year-over-year
Areas to Watch
Weak financial health signals
Earnings declined 69.0%
0.0% earnings growth
Trading at 20.6x book value
ROE of -72.7% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : DOCS
The strongest argument for DOCS centers on Profit Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 30.4% and operating margin at 21.6%. PEG of 0.59 suggests the stock is reasonably priced for its growth.
Bull Case : TEM
The strongest argument for TEM centers on Revenue Growth. Revenue growth of 36.1% demonstrates continued momentum.
Bear Case : DOCS
The primary concerns for DOCS are Piotroski F-Score, EPS Growth.
Bear Case : TEM
The primary concerns for TEM are EPS Growth, Price/Book, Return on Equity. Debt-to-equity of 3.17 is elevated, increasing financial risk.
Key Dynamics to Monitor
DOCS profiles as a mature stock while TEM is a hypergrowth play — different risk/reward profiles.
TEM carries more volatility with a beta of 3.62 — expect wider price swings.
TEM is growing revenue faster at 36.1% — sustainability is the question.
DOCS generates stronger free cash flow (107M), providing more financial flexibility.
Bottom Line
DOCS scores higher overall (62/100 vs 31/100), backed by strong 30.4% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Doximity Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Doximity, Inc. (Ticker: DOCS) is a U.S. healthcare technology company that operates a digital platform tailored for medical professionals. The company’s cloud-based network provides secure communication and collaboration tools, telemedicine services, clinical workflow solutions, and access to medical news, research, and career-management features for physicians, nurse practitioners, physician assistants, and other clinicians. Headquartered in San Francisco, California, Doximity’s Class A common stock trades on the New York Stock Exchange under the ticker DOCS.
Tempus AI, Inc. Class A Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?